Nigel S. Key

Guidelines for the management of hemophilia

Alok Srivastava, A. Brewer, Evelien P. Mauser‐Bunschoten et al. · Haemophilia · 2012 · 1.9K citations · Full text

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

Gary H. Lyman, Kari Bohlke, Alok A. Khorana et al. · Journal of Clinical Oncology · 2015 · 1.4K citations · Full text

Definitions in hemophilia: communication from the SSC of the ISTH

Victor S. Blanchette, Nigel S. Key, L.R. Ljung et al. · Journal of Thrombosis and Haemostasis · 2014 · 717 citations

Immunohematology, Laboratory Hematology, Granulocyte +6

Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytes

Arun S. Shet, Ömer Aras, Kalpna Gupta et al. · Blood · 2003 · 524 citations

Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study

Steven W. Pipe, Midori Shima, Michaela Lehle et al. · The Lancet Haematology · 2019 · 373 citations · Full text

Haven 4, Hematology, Non-randomised Phase 3 +2